Max Keller

1.4k total citations
73 papers, 984 citations indexed

About

Max Keller is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Max Keller has authored 73 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 45 papers in Cellular and Molecular Neuroscience and 8 papers in Oncology. Recurrent topics in Max Keller's work include Receptor Mechanisms and Signaling (43 papers), Neuropeptides and Animal Physiology (39 papers) and Chemical Synthesis and Analysis (26 papers). Max Keller is often cited by papers focused on Receptor Mechanisms and Signaling (43 papers), Neuropeptides and Animal Physiology (39 papers) and Chemical Synthesis and Analysis (26 papers). Max Keller collaborates with scholars based in Germany, Estonia and United Kingdom. Max Keller's co-authors include Günther Bernhardt, Armin Buschauer, Burkhard König, David Wifling, Peter Gmeiner, Lisa Schindler, Nikola Pluym, Harald Hübner, Erich Schneider and Christoph Hutzler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Max Keller

72 papers receiving 971 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Keller Germany 19 737 485 134 108 98 73 984
Nuška Tschammer Germany 21 924 1.3× 459 0.9× 155 1.2× 90 0.8× 140 1.4× 47 1.2k
Li Niu United States 21 851 1.2× 441 0.9× 84 0.6× 52 0.5× 97 1.0× 62 1.3k
Joel Karpiak United States 13 729 1.0× 330 0.7× 59 0.4× 153 1.4× 59 0.6× 14 991
Mireia Olivella Spain 16 629 0.9× 294 0.6× 61 0.5× 63 0.6× 85 0.9× 32 833
Mark R. Spaller United States 22 909 1.2× 323 0.7× 264 2.0× 41 0.4× 81 0.8× 43 1.4k
Gianluigi Caltabiano Spain 18 732 1.0× 338 0.7× 172 1.3× 59 0.5× 57 0.6× 30 1.0k
François‐Xavier Cantrelle France 23 929 1.3× 178 0.4× 86 0.6× 78 0.7× 45 0.5× 71 1.4k
Brendan Kelly Ireland 16 591 0.8× 211 0.4× 182 1.4× 45 0.4× 34 0.3× 25 875
C. Parthier Germany 18 798 1.1× 264 0.5× 72 0.5× 58 0.5× 135 1.4× 32 1.2k
David Timms United Kingdom 14 924 1.3× 352 0.7× 374 2.8× 35 0.3× 119 1.2× 27 1.3k

Countries citing papers authored by Max Keller

Since Specialization
Citations

This map shows the geographic impact of Max Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Keller more than expected).

Fields of papers citing papers by Max Keller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Keller. The network helps show where Max Keller may publish in the future.

Co-authorship network of co-authors of Max Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Max Keller. A scholar is included among the top collaborators of Max Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Keller. Max Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beck, Sebastian, et al.. (2025). The quantity of ligand–receptor interactions between nanoparticles and target cells. Nanoscale Horizons. 10(4). 803–823. 6 indexed citations
2.
Keller, Max, et al.. (2024). Differential uptake of arginine derivatives by the human heteromeric amino acid transporter b0,+AT-rBAT (SLC7A9-SLC3A1). Naunyn-Schmiedeberg s Archives of Pharmacology. 398(4). 4419–4434.
3.
Keller, Max, et al.. (2024). Spectroscopic Study on the Complexation of trivalent Actinide and Lanthanide ions with TEDGA in Solution. European Journal of Inorganic Chemistry. 27(10). 2 indexed citations
4.
Kopanchuk, Sergei, Santa Veikšina, Harald Hübner, et al.. (2024). Dually Labeled Neurotensin NTS1R Ligands for Probing Radiochemical and Fluorescence-Based Binding Assays. Journal of Medicinal Chemistry. 67(18). 16664–16691. 1 indexed citations
5.
Keller, Max, Lisa Schindler, Steffen Pockes, et al.. (2024). Initial Characterization of a Transgenic Mouse with Overexpression of the Human H1-Histamine Receptor on the Heart. Journal of Pharmacology and Experimental Therapeutics. 389(2). 174–185. 5 indexed citations
6.
Schubert, Mario, et al.. (2023). Stereochemistry-Driven Interactions of α,γ-Peptide Ligands with the Neuropeptide Y Y4-Receptor. Journal of Medicinal Chemistry. 66(14). 9642–9657. 2 indexed citations
7.
Keller, Max, et al.. (2023). [3H]UR-JG102–A Radiolabeled Cyclic Peptide with High Affinity and Excellent Selectivity for the Neuropeptide Y Y4 Receptor. Journal of Medicinal Chemistry. 66(19). 13788–13808. 4 indexed citations
8.
Keller, Max, et al.. (2023). Characterization of Fluorescent Dyes Frequently Used for Bioimaging: Photophysics and Photocatalytical Reactions with Proteins. The Journal of Physical Chemistry B. 127(44). 9532–9542. 7 indexed citations
9.
Keller, Max, et al.. (2023). Extended Metadynamics Protocol for Binding/Unbinding Free Energies of Peptide Ligands to Class A G-Protein-Coupled Receptors. Journal of Chemical Information and Modeling. 64(1). 205–218. 8 indexed citations
10.
Fishman, Dmytro, Leopold Parts, Lukas Grätz, et al.. (2022). Live-cell microscopy or fluorescence anisotropy with budded baculoviruses—which way to go with measuring ligand binding to M 4 muscarinic receptors?. Open Biology. 12(6). 220019–220019. 6 indexed citations
11.
Tan, Qiuxiang, Shuo Han, Hongyu Wang, et al.. (2022). Receptor-specific recognition of NPY peptides revealed by structures of NPY receptors. Science Advances. 8(18). eabm1232–eabm1232. 34 indexed citations
12.
Kopanchuk, Sergei, Dieter Schollmeyer, Steffen Lüdeke, et al.. (2022). Structure-Based Design of High-Affinity Fluorescent Probes for the Neuropeptide Y Y1 Receptor. Journal of Medicinal Chemistry. 65(6). 4832–4853. 15 indexed citations
13.
Schindler, Lisa, et al.. (2022). Neurotensin analogs by fluoroglycosylation at Nω-carbamoylated arginines for PET imaging of NTS1-positive tumors. Scientific Reports. 12(1). 15028–15028. 3 indexed citations
14.
Fischer, Oliver, Peter Gmeiner, Roger Jan Kutta, et al.. (2022). Synthesis, Characterization, and Application of Muscarinergic M3 Receptor Ligands Linked to Fluorescent Dyes. Journal of Medicinal Chemistry. 65(24). 16494–16509. 3 indexed citations
15.
Wifling, David, et al.. (2021). Dibenzodiazepinone-type muscarinic receptor antagonists conjugated to basic peptides: Impact of the linker moiety and unnatural amino acids on M2R selectivity. European Journal of Medicinal Chemistry. 213. 113159–113159. 5 indexed citations
16.
Wifling, David, Harald Hübner, Günther Bernhardt, et al.. (2020). Red-Emitting Dibenzodiazepinone Derivatives as Fluorescent Dualsteric Probes for the Muscarinic Acetylcholine M2 Receptor. Journal of Medicinal Chemistry. 63(8). 4133–4154. 13 indexed citations
17.
Wifling, David, et al.. (2019). Conjugation of Short Peptides to Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Determines M2R Selectivity. Journal of Medicinal Chemistry. 62(11). 5358–5369. 10 indexed citations
18.
Keller, Max, Lisa Schindler, Timo Littmann, et al.. (2019). Fluorescence Labeling of Neurotensin(8–13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity. ACS Medicinal Chemistry Letters. 11(1). 16–22. 20 indexed citations
19.
20.
Wifling, David, et al.. (2017). Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M2 Muscarinic Acetylcholine Receptor. Journal of Medicinal Chemistry. 60(8). 3314–3334. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nuška Tschammer Breakdown of academic impact, for papers by Li Niu Breakdown of academic impact, for papers by Joel Karpiak Breakdown of academic impact, for papers by Mireia Olivella Breakdown of academic impact, for papers by Mark R. Spaller Breakdown of academic impact, for papers by Gianluigi Caltabiano Breakdown of academic impact, for papers by François‐Xavier Cantrelle Breakdown of academic impact, for papers by Brendan Kelly Breakdown of academic impact, for papers by C. Parthier Breakdown of academic impact, for papers by David Timms
Rankless by CCL
2026